The widespread use of GLP-1 therapies, particularly in obesity, has raised questions about appropriate prescribing, long-term safety, and equitable access
Or stick to the dosage prescribed by your treating doctor based on your condition
A screening with the biosensor as for the -BBH was not chosen because external supplementation of aldehydes can have toxic effects on the cells due to their high reactivity and it is uncertain that the aldehyde is taken up by the cells (Kunjapur and Prather, 2015)
Novo Nordisk has announced the results of a trial of CagriSema for the treatment of stage 2 diabetes, which proved that CagriSema's hypoglycemic effect is better than that of semeglutide, and nearly 90% of subjects have achieved the HbA1c goal
Month 4 and beyond: finding your maintenance dose After month 4 and onwards, you will continue taking a maintenance dose, which may range between 1.0 mg and 2.4 mg weekly